Search
Search Results
##search.searchResults.foundPlural##
-
-
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2522PDF: 2198HTML: 269 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6035PDF: 1643HTML: 1690Untitled: 300 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277971PDF: 1929HTML: 3921 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3266PDF: 1135HTML: 3384 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
3083PDF: 1062HTML: 2132Cover letter: 247 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5061PDF: 1936HTML: 2910Untitled: 355 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1707PDF: 913Suppl. Files: 382Html: 181 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2180PDF: 2057HTML: 816 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2663PDF: 999HTML: 2590 -
-
COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia
1089PDF: 795HTML: 172 -
-
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4276PDF: 1264HTML: 2140Fig.1: 254Fig. 2: 151Table 1: 265Table2: 292Table 3: 288 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1784PDF: 723HTML: 2459 -
TREATMENT OF NEWLY DIAGNOSED POEMS SYNDROME: BORTEZOMIB OR LENALIDOMIDE? EXPERIENCE FROM TWO COUNTRIES
138PDF: 70Suppl. Files: 21Html: 36Html Suppl. Files: 41 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
1130PDF: 655Html: 334Suppl. Files: 215 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2674HTML: 374PDF: 998 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1854PDF: 1419HTML: 188 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2363PDF: 595HTML: 200 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1743PDF: 1002HTML: 419 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1507PDF: 998HTML: 1312fig 1A: 254figure1B: 220 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2563PDF: 1994HTML: 203 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
3057PDF: 1062HTML: 675 -







